Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) EPS (Basic): 2019-2025

Historic EPS (Basic) for Eton Pharmaceuticals (ETON) over the last 7 years, with Sep 2025 value amounting to -$0.07.

  • Eton Pharmaceuticals' EPS (Basic) fell 450.00% to -$0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.26, marking a year-over-year decrease of 18.18%. This contributed to the annual value of -$0.15 for FY2024, which is 275.00% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its EPS (Basic) stood at -$0.07 for Q3 2025, which was up 30.00% from -$0.10 recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year EPS (Basic) high stood at $0.21 for Q1 2021, and its period low was -$210 during Q1 2022.
  • Its 3-year average for EPS (Basic) is -$0.04, with a median of -$0.06 in 2025.
  • As far as peak fluctuations go, Eton Pharmaceuticals' EPS (Basic) crashed by 100,100.00% in 2022, and later skyrocketed by 400.00% in 2023.
  • Eton Pharmaceuticals' EPS (Basic) (Quarterly) stood at $0.04 in 2021, then grew by 0.00% to $0.04 in 2022, then crashed by 325.00% to -$0.09 in 2023, then surged by 66.67% to -$0.03 in 2024, then crashed by 450.00% to -$0.07 in 2025.
  • Its last three reported values are -$0.07 in Q3 2025, -$0.10 for Q2 2025, and -$0.06 during Q1 2025.